OpenVSafe by OpenVAERS
Search V-safe

K45-25939-65249

3 vaccinations 2 coded responses 15 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
662 / KS
Registered
2021-03-04
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-05
    Dose 1 — Moderna
  2. 2021-03-04
    Registered in v-safe
  3. 2021-03-04
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-03-05
    Dose 2 — Moderna
  5. 2021-03-05
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-03-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-03-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-02
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-09
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-09-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-12-06
    Dose 3 — Moderna
  18. 2022-03-05
    Survey response — 12 months, dose 2
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cold
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-12-06
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-05Moderna
22021-03-05Moderna
32021-12-06Moderna No

Free text

Release 11 — 12 months, dose 2

2022-03-05

Symptoms: Cold

Release 12 — 12 months, dose 3

2022-12-06

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release